PubRank

E Jaros

Author PubWeight™ 51.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004 2.23
2 Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol 2009 2.21
3 P53 overexpression in head and neck carcinoma and radiotherapy results. Int J Radiat Oncol Biol Phys 1996 2.06
4 Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000 1.85
5 Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 2008 1.83
6 Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999 1.48
7 Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol 1988 1.33
8 Involvement of peripheral and central nerves in murine dystrophy. Ann N Y Acad Sci 1979 1.32
9 Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006 1.29
10 Axoplasmic flow in axonal neuropathies. II. Axoplasmic flow in mice with motor neuron disease and muscular dystrophy. Brain 1973 1.22
11 Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 2000 1.20
12 Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature 1975 1.16
13 Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002 1.13
14 Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol 2006 1.08
15 Development of the amyelinated lesion in the ventral root of the dystrophic mouse. Ultrastructural, quantitative and autoradiographic study. J Neurol Sci 1978 1.07
16 Multiple system atrophy: cellular and molecular pathology. Mol Pathol 2001 1.05
17 Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology 2004 1.02
18 Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience 2002 1.01
19 Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathol Appl Neurobiol 2004 0.99
20 Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol 2000 0.96
21 Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. Br J Cancer 1995 0.95
22 SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004 0.95
23 Atypical axon-Schwann cell relationships in the common peroneal nerve of the dystrophic mouse: an ultrastructural study. Neuropathol Appl Neurobiol 1979 0.94
24 Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 2004 0.93
25 Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions. Neuropathol Appl Neurobiol 2009 0.90
26 Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. J Chem Neuroanat 2003 0.89
27 A developmentally regulated disappearance of slow myosin in fast-type muscles of the mouse. FEBS Lett 1984 0.89
28 Quantitative studies of the abnormal axon-Schwann cell relationship in the peripheral motor and sensory nerves of the dystrophic mouse. Brain Res 1983 0.88
29 Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. Eur J Neurosci 1999 0.86
30 Clinical neurochemistry: developments in dementia research based on brain bank material. J Neural Transm (Vienna) 1998 0.86
31 Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes. Dement Geriatr Cogn Disord 2008 0.85
32 Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 1995 0.85
33 Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Neuroscience 1999 0.85
34 Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord 2000 0.84
35 Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur J Cancer 1997 0.84
36 Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. Neuroreport 1998 0.84
37 Quantitative neurodegenerative pathology does not explain the degree of hippocampal atrophy on MRI in degenerative dementia. Int J Geriatr Psychiatry 2012 0.82
38 Temporal lobe pathology of human patients with neurofilament inclusion disease. Neurosci Lett 2004 0.82
39 Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking. Neuropathol Appl Neurobiol 2005 0.81
40 Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology. Biol Psychiatry 2001 0.81
41 The nodes of Ranvier in the nerves of mice with muscular dystrophy. J Neuropathol Exp Neurol 1977 0.81
42 Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathol Appl Neurobiol 2012 0.80
43 The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system. Br J Cancer 2002 0.79
44 Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03. Neurosci Lett 1999 0.78
45 Depression in late life, cognitive decline and white matter pathology in two clinico-pathologically investigated cases. Int J Geriatr Psychiatry 2001 0.78
46 Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies. Pharmacol Biochem Behav 2001 0.78
47 [Intraoperative enteroscopy--personal experience from 1995 to 2002]. Cas Lek Cesk 2003 0.76
48 Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression. Neurosci Lett 2002 0.76
49 Defective differentiation of peripheral nerves in the dystrophic mouse. Brain Res 1983 0.76
50 Frontotemporal lobar degeneration in a very young patient is associated with fused in sarcoma (FUS) pathological changes. Neuropathol Appl Neurobiol 2012 0.75
51 [Torsion of the spleen--an unusual cause of sudden acute abdomen]. Rozhl Chir 2002 0.75
52 What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)? J Neurol Neurosurg Psychiatry 2010 0.75
53 Clinical presentations in monozygotic twins with dementia with Lewy bodies. J Am Med Dir Assoc 2003 0.75
54 Effects of tenotomy on muscle histology and energy metabolism in normal and dystrophic mice. J Neurol Sci 1989 0.75
55 Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration. Acta Neurol Scand 1997 0.75
56 [Appendiceal mucocele]. Rozhl Chir 2004 0.75
57 Spontaneous electrical activity in muscles of dystrophic (dy/dy) mice. J Neurol Sci 1986 0.75